The landscape of tumor treatment is constantly evolving, with a growing emphasis on identifying novel therapeutic targets for drug creation. Traditional therapies often strike rapidly dividing cells, leading to significant side outcomes. However, the emergence of sophisticated genomic profiling techniques has altered our perception of cancer biolog